Diener HC, Sacco R, Yusuf S, Steering Committee; PRoFESS Study Group: Rationale, design and baseline data in a randomized, double-blind, controlled trial comparing two antithrombotic regimes (a fixed-dose combination of extended-release dipyridamole plus ASA with clopidogrel) and telmisartan versus placebo in patients with strokes: the Prevention Regime for Effectively Avoiding Second Strokes Trial (PRoFESS). Cerebrovasc Dis2007; 23:368–80.
2.
NorrisJ: The ideal antiplatelet drug for stroke prevention – still elusive. Stroke2008; 39:1076–7.
3.
AndersonC: Neuroprotection for angiotensin receptor blockers?J Hypertens2008; 26:853.
4.
The ONTARGET Investigators: Yusef, S, Teo KK, Pogue J et al. Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med2008; 358:1547–59.
